Sign In
Buy ASH
$57.00
-0.580 (-1.01%)
At Close: Jun 03, 2026
Ashland Place Completes Two New Financing Facilities for Sirius Aviation Capital
09:00am, Tuesday, 29'th Apr 2025
NEW YORK , April 29, 2025 /PRNewswire/ -- Ashland Place Finance LLC ("Ashland Place"), a commercial aviation financing platform, today announced the completion of two new facilities for Sirius Aviatio
Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline
11:07am, Wednesday, 23'rd Apr 2025
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast
06:30am, Thursday, 17'th Apr 2025
WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, Ap
Ashland Wraps Up Expansion of Pharmaceutical Plant in Brazil
01:05pm, Thursday, 03'rd Apr 2025
ASH is investing in modernizing equipment for microbial protection in personal care applications at its Technical Center in Sao Paulo.
Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China Increased production capacity and market
Ashland to host 2025 Innovation Day for analysts and investors
06:59am, Friday, 28'th Mar 2025
WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company's Bridgewater, New Jersey facility, Thursday, May 2
Ashland Wraps Up Divestment of Avoca Business to Mane
10:20am, Tuesday, 18'th Mar 2025
ASH closes the sales of its Avoca business, the last entity remaining from the Pharmachem acquisition.
Ashland completes sale of Avoca business to Mane
07:00am, Monday, 17'th Mar 2025
Wilmington, Del., March 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has completed the sale of its Avoca business to Mane effective March 14, 2025. Financial terms of
Ashland Presents Attractive Upside Emerging From The Downcycle
02:14pm, Thursday, 27'th Feb 2025
Ashland is generating attractive free cash flow and is well-positioned to achieve its 2027 target of $600 million EBITDA and 50% FCF conversion rate. Despite the stock selling off over the last 8 mont
TScan Therapeutics: Finding Their Footing After An Eventful ASH Meeting
03:14am, Monday, 10'th Feb 2025
TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia, showing promising phase 1 results but potential GvHD risks. TCRX's financials are
Ashland's Earnings Outpace Estimates, Revenues Miss in Q1
07:31am, Thursday, 30'th Jan 2025
Organic sales volume growth in ASH's Personal Care, Specialty Additives and Intermediates segments largely offset lower volumes in Life Sciences in Q1.
Ashland Inc. (ASH) Q1 2025 Earnings Call Transcript
09:24pm, Wednesday, 29'th Jan 2025
Ashland Inc. (NYSE:ASH ) Q1 2025 Earnings Conference Call January 29, 2025 9:00 AM ET Company Participants William Whitaker - VP, Finance and Director, IR Guillermo Novo - Chair and CEO Kevin Willis -
New Strong Sell Stocks for January 29th
04:20am, Wednesday, 29'th Jan 2025
ARCAY, ASH and DNKEY have been added to the Zacks Rank #5 (Strong Sell) List on January 29, 2024.
Here's What Key Metrics Tell Us About Ashland (ASH) Q1 Earnings
08:01pm, Tuesday, 28'th Jan 2025
Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree
Ashland (ASH) Surpasses Q1 Earnings Estimates
07:26pm, Tuesday, 28'th Jan 2025
Ashland (ASH) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.45 per share a year ago.
